TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients. 

¿El TAVI en válvulas bicúspides presenta mayor mismatch protésico?

The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of echocardiograms and autopsies. We know this is a challenging anatomy for TAVR, because of greater calcification, which has been associated to increased complications and even higher mortality in the midterm, in some registries. Another potential issue is prosthetic mismatch (PPM), linked to worse evolution at long term. 

This analysis of the OCEAN TAVI registry included 7,051 patients, 503 (7.13%) presenting BAV aortic stenosis (AS), and the rest a tricuspid aortic valve (TAV) AS. Balloon expandable (BEV) Sapien XT and Sapien 3, and self-expanding valves (SEV) CoreValve and Evolut R/PRO were used. 

Read also: ROLLER COASTR-EPIC22: Comparison of Plaque Modification Techniques in Severely Calcified Coronary Lesions.

The heterogeneous groups were matched using propensity score, leaving 497 in each one. Mean patient age was 84, over 60% were women, mortality STS was 6%, 62% presented hypertension, 22% diabetes, 15% atrial fibrillation, and 67% kidney function deterioration. 

The transfemoral approach was used in 97% of cases, with no differences in type or valve diameter; the most used in both groups was the 29 mm valve. During the procedure, major and minor bleeding were more frequent among TAV patients (7.2% vs. 3%, p=0.003; 6% vs. 2.2%, p=0.002, respectively). There were no differences in aortic root lesion, coronary obstruction, conversion to surgery, stroke, life threatening bleeding, vascular complications or need for pacemaker implantation. Hospital stay was similar. 

At 30 days, mortality was 1% in both groups. 

Read also: Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation.

At two year followup, there were no differences in mortality, effective aortic area, indexed area, peak velocity or mean gradient. However, the presence of PPM was higher among TAV patients (moderate PPM 11.7% vs. 4.4%, severe 1.4% vs. 1%; p=0.001). PPM seemed associated to higher mortality, though with no statistical significance (p=0.065), and in the propensity score matched population, there was no significant impact (p=0.90).

Conclusion

Severe prosthetic mismatch could be associated to all-cause mortality, However, moderate and severe prosthetic mismatch was more frequent in patients with tricuspid aortic stenosis, vs bicuspid. 

Original Title: Incidence and Prognosis of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement for Bicuspid Aortic Stenosis

Reference: Futoshi Yamanaka, et al. JACC Cardiovasc Interv. 2025;18:492–502.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...